UNSPSC 51413209: Trimetazidine hydrochloride

This classification denotes a cardiotonic agent with the molecular formula C14H22N2O3.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 48V6723Z1P, chemically known as 1-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride but more generally known as trimetazidine dihydrochloride, which bears US NIH Compound Identifier 83201. European Medicines Agency schedules Trimetazidine dihydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12374MIG.

Most nations, for tariff and trade purposes, schedule trimetazidine hydrochloride under HS 29335995 and SITC 51576. SMILES: COC1CCC(C(C1OC)OC)CN2CCNCC2.CL.CL.

UNSPSC 51413209 Trimetazidine hydrochloride is a Commodity code that covers specific branded and generic pharmaceutical products purchased by state and local health systems, fire rescue agencies, and state health benefit programs for emergency medical services and pharmacy benefit administration. State and local governments procure this medication as part of broader advanced life support drug inventories for emergency medical services delivery and as a line item within larger generic pharmaceutical contracts serving multi-state cooperative purchasing alliances and state Medicaid or employee health plans. Issuing bodies include municipal fire rescue departments (such as Tampa Fire Rescue operating through city purchasing offices), state health and human services commissions managing pharmacy benefit programs, and multi-state cooperative purchasing consortia administering contracts on behalf of member state agencies and local facilities.

Recent activity shows the code in use across Florida and Minnesota-led multi-state cooperative purchasing. The City of Tampa's Purchasing Department issued an IFB (Bid No. 26-P-00188) in April 2026 for Advanced Life Support Medications to supply Tampa Fire Rescue, with bids due April 8, 2026 and an estimated contract value of $40,000.00; the solicitation included a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (Solicitation S1070000015802) due March 26, 2026 for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local facilities including Oregon, with pricing weighted 75 percent in evaluation. The Texas Health and Human Services Commission posted an RFI (HHS0017013) in April 2026 to gather vendor capabilities for a direct-to-manufacturer pharmacy initiative, signaling future formal procurement activity in that state. The code shows limited recent activity overall; trimetazidine hydrochloride itself appears infrequently in posted state and local solicitations, though the broader pharmaceutical supply contracts under which it may be listed are active in multi-state cooperative purchasing environments.